Nicotinamide riboside is uniquely and orally bioavailable in mice and humans SAJ Trammell, MS Schmidt, BJ Weidemann, P Redpath, F Jaksch, ... Nature communications 7 (1), 12948, 2016 | 696 | 2016 |
Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice SAJ Trammell, BJ Weidemann, A Chadda, MS Yorek, A Holmes, ... Scientific reports 6 (1), 26933, 2016 | 343 | 2016 |
NAD+ controls circadian reprogramming through PER2 nuclear translocation to counter aging DC Levine, H Hong, BJ Weidemann, KM Ramsey, AH Affinati, ... Molecular cell 78 (5), 835-849. e7, 2020 | 158 | 2020 |
Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure SM Bahr, BJ Weidemann, AN Castro, JW Walsh, O Deleon, CML Burnett, ... EBioMedicine 2 (11), 1725-1734, 2015 | 149 | 2015 |
Time-restricted feeding mitigates obesity through adipocyte thermogenesis C Hepler, BJ Weidemann, NJ Waldeck, B Marcheva, J Cedernaes, ... Science 378 (6617), 276-284, 2022 | 98 | 2022 |
Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent NK Littlejohn, RB Siel Jr, P Ketsawatsomkron, CJ Pelham, NA Pearson, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2013 | 90 | 2013 |
Angiotensin AT1A receptors on leptin receptor–expressing cells control resting metabolism KE Claflin, JA Sandgren, AM Lambertz, BJ Weidemann, NK Littlejohn, ... The Journal of clinical investigation 127 (4), 1414-1424, 2017 | 79 | 2017 |
Suppression of resting metabolism by the angiotensin AT2 receptor NK Littlejohn, HL Keen, BJ Weidemann, KE Claflin, KV Tobin, KR Markan, ... Cell reports 16 (6), 1548-1560, 2016 | 50 | 2016 |
Dietary sodium suppresses digestive efficiency via the renin-angiotensin system BJ Weidemann, S Voong, FI Morales-Santiago, MZ Kahn, J Ni, ... Scientific reports 5 (1), 11123, 2015 | 45 | 2015 |
A Mitochondrial-Targeted Coenzyme Q Analog Prevents Weight Gain and Ameliorates Hepatic Dysfunction in High-Fat–Fed Mice BD Fink, JA Herlein, DF Guo, C Kulkarni, BJ Weidemann, L Yu, JL Grobe, ... Journal of Pharmacology and Experimental Therapeutics 351 (3), 699-708, 2014 | 45 | 2014 |
A role for alternative splicing in circadian control of exocytosis and glucose homeostasis B Marcheva, M Perelis, BJ Weidemann, A Taguchi, H Lin, C Omura, ... Genes & Development 34 (15-16), 1089-1105, 2020 | 30 | 2020 |
Selective deletion of renin-b in the brain alters drinking and metabolism K Shinohara, P Nakagawa, J Gomez, DA Morgan, NK Littlejohn, ... Hypertension 70 (5), 990-997, 2017 | 25 | 2017 |
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failure B Marcheva, BJ Weidemann, A Taguchi, M Perelis, KM Ramsey, ... Elife 11, e75132, 2022 | 15 | 2022 |
Repression of latent NF-κB enhancers by PDX1 regulates β cell functional heterogeneity BJ Weidemann, B Marcheva, M Kobayashi, C Omura, MV Newman, ... Cell Metabolism 36 (1), 90-102. e7, 2024 | 11 | 2024 |
A day in the life of chromatin: how enhancer–promoter loops shape daily behavior BJ Weidemann, KM Ramsey, J Bass Genes & development 32 (5-6), 321-323, 2018 | 7 | 2018 |
A window in time for β-cell regeneration BJ Weidemann, J Bass Genes & Development 34 (23-24), 1559-1561, 2020 | 3 | 2020 |
Transfer of Obesity via the Gut Microbiome is Mediated Specifically through Suppression of Non‐Aerobic Resting Metabolism J Grobe, S Bahr, B Weidemann, C Burnett, N Pearson, O DeLeon, ... The FASEB Journal 29, 857.2, 2015 | 2 | 2015 |
Angiotensin suppresses thermogenic capacity through adipose AT2 receptors JL Grobe, S Park, NK Littlejohn, BA Buehrer, BJ Weidemann, HL Keen, ... Hypertension 60 (suppl_1), A20-A20, 2012 | 2 | 2012 |
Genomic Basis for the Circadian Regulation of Beta-Cell Function and Glucose Homeostasis B Weidemann Northwestern University, 2023 | | 2023 |
Pharmacologic rescue of circadian β-cell failure through P2Y1 purinergic receptor identified by small-molecule screen B Marcheva, BJ Weidemann, A Taguchi, M Perelis, KM Ramsey, ... bioRxiv, 2021.11. 05.467499, 2021 | | 2021 |